By Harry Boxer
Tandem Diabetes Care, Inc.
Here are four stocks moving in response to, or just ahead of, earnings.
• Array BioPharma gained $1.16 to $16.20 Wednesday after posting quarterly results that topped Wall Street expectations. The move broke the stock out above key lateral resistance as it has emerged from a head-and-shoulders bottoming pattern. Volume of 6.5 million shares was the biggest for the drug developer since May when its stock last broke out. Targets are $18 and then $20.
• CareDx /zigman2/quotes/200138382/composite CDNA +1.08% jumped $1.56 to $26.11 on over $1 million shares traded Wednesday, more than 1 1/2 times its average volume. The transplant-diagnostics company is scheduled to report third-quarter results Nov. 8. The move popped the stock out of a month-long coiling pattern. A move through the Oct. 1 high near $19.50 could accelerate the stock toward the channel top in the high-$30s.
• FireEye /zigman2/quotes/204730283/composite FEYE +0.07% leaped $1.64 to $18.49 Wednesday on huge volume of 18 million shares, 3 1/2 times its average volume. The cybersecurity company released better-than-expected third-quarter results after the close Tuesday. The stock appears to be emerging out of a multi-year basing pattern. Resistance is at the April high of $19.36. A move through that could get the stock toward the channel top at around $22.
• Tandem Diabetes Care /zigman2/quotes/208680527/composite TNDM +6.25% rose $2.92 to $37.61 Wednesday on 2.2 million shares traded. The developer of insulin-delivery systems is scheduled to report after the close today. Wednesday’s move broke the stock above the declining tops line from its pullback off the September high. The stock faces next lateral resistance just above here at $37.70, and then minor resistance at $40.50, a move through which could accelerate it higher.
The writer has no holdings in any securities mentioned.
Harry Boxer is founder of TheTechTrader.com, a live trading room featuring his stock picks, technical market analysis, and live chart presentations.